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Two modes of catalysis have evolved
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Thioredoxin reductase (EC 1.6.4.5) is a widely distributed flavoprotein that catalyzes the NADPH-dependent
reduction of thioredoxin. Thioredoxin plays several key roles in maintaining the redox environment of the cell.
Like all members of the enzyme family that includes lipoamide dehydrogenase, glutathione reductase and
mercuric reductase, thioredoxin reductase contains a redox active disulfide adjacent to the flavin ring. Evolution
has produced two forms of thioredoxin reductase, a protein in prokaryotes, archaea and lower eukaryotes having a
Mr of 35 000, and a protein in higher eukaryotes having a Mr of 55 000. Reducing equivalents are transferred
from the apolar flavin binding site to the protein substrate by distinct mechanisms in the two forms of thioredoxin
reductase. In the low Mr enzyme, interconversion between two conformations occurs twice in each catalytic
cycle. After reduction of the disulfide by the flavin, the pyridine nucleotide domain must rotate with respect to
the flavin domain in order to expose the nascent dithiol for reaction with thioredoxin; this motion repositions the
pyridine ring adjacent to the flavin ring. In the high Mr enzyme, a third redox active group shuttles the reducing
equivalent from the apolar active site to the protein surface. This group is a second redox active disulfide in
thioredoxin reductase from Plasmodium falciparum and a selenenylsulfide in the mammalian enzyme.
P. falciparum is the major causative agent of malaria and it is hoped that the chemical difference between the two
high Mr forms may be exploited for drug design.
Keywords: flavoprotein; thioredoxin; thioredoxin reductase; selenium, disulfide; dithiol; selenenylsulfide; redox
active; ribonucleotide reductase; transcription factor activation; drug design.
With most enzymes, the structure, and the mechanism that is
associated with it, are essentially the same regardless of the
enzyme source, whether that be prokaryote, archaea or
eukaryote, i.e. evolution has decided on one way to effect
catalysis. However, there are enzymes where the same reaction
is catalyzed by more than one structure and mechanism (e.g.
methionine synthase [1]), and thioredoxin reductase is another
such enzyme [2,3]. Thioredoxin reductase is a flavoprotein that
catalyzes the reduction of thioredoxin by NADPH [4,5]. The
substrate thioredoxin is a small protein of Mr 12 000 which in
its dithiol state plays a key role in maintaining the redox
environment of the cell [6]. Important functions of reduced
thioredoxin include the reduction of nucleotides to deoxy-
nucleotides and the modulation of transcription factors such as
NF-kB in eukaryotes [6±8].
C H A R A C T E R I S T I C S O F A N E N Z Y M E
F A M I L Y
Thioredoxin reductase is a member of the family of dimeric
flavoenzymes that catalyze the transfer of electrons between
pyridine nucleotides and disulfide/dithiol compounds and pro-
mote catalysis via FAD and a redox active disulfide (Table 1)
[9±13]. The family includes lipoamide dehydrogenase, gluta-
thione reductase and mercuric reductase, which vary only
slightly in structure and mechanism depending on the source. In
these three cases, catalysis has evolved in only one way. On the
other hand, two distinct types of thioredoxin reductase have
evolved [2,3]. Both are dimeric, and catalysis is again brought
about by FAD and a redox active disulfide. Thioredoxin
reductase isolated from Plasmodium falciparum and other
higher eukaryotes has a subunit Mr of 55 000, like that of
glutathione reductase and lipoamide dehydrogenase, while
thioredoxin reductase from lower species, including lower
plants and fungi, lacks a separate interface domain and has a
subunit Mr of 35 000. The low Mr type from Escherichia coli
was reviewed in 1995 and further features of its structure will
be covered in the first part of this review [5]. We will then turn
to recent work on the high Mr form from human placenta and
from P. falciparum, the major causative agent of malaria
[2,14,15].
The common chemistry effected by the disulfide reductase
family of enzymes involves the transfer of reducing equivalents
from the pyridine nucleotide substrate to the disulfide substrate.
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A hydride ion passes from the NAD(P)H to the flavin and the
reducing equivalent is transferred from the reduced flavin to the
active site disulfide. In the absence of an acceptor substrate, a
thiolate±flavin charge transfer complex is stabilized as shown
schematically for glutathione reductase and lipoamide dehydro-
genase in the top line of Fig. 1 [9]. This CT complex is
characterized by an absorbance peak around 540 nm [16]. The
flavin reduction and its reoxidation by the disulfide require the
apolar medium provided by the enzyme. The subsequent
dithiol±disulfide interchange between the nascent dithiol and
the disulfide substrate takes place in a more polar medium.
The path of electrons in catalysis by glutathione reductase or
lipoamide dehydrogenase is clear: from the nicotinamide ring
of NAD(P)H on the re side of the isoalloxazine ring to the
disulfide on the si side of FAD and on to the disulfide substrate
[17,18]. (Re and si in nontechnical terms refer to specific sides
of the isoalloxazine ring; the re side has the benzene ring on the
left when the ribytyl side chain is at the bottom and the si
side is the opposite side, e.g. in Fig. 2, S138 is on the re side.)
Interchange between the nascent dithiol and the substrate
disulfide is catalyzed by a nearby histidine residue [17,19].
Only one thiol can interact with the flavin (referred to as the
flavin interacting thiol) and the remaining thiol can only
participate in dithiol±disulfide interchange with the substrate
(referred to as the interchange thiol) [17,20,21]. The milieu of
the interchange thiol is more polar than that of the flavin
interacting thiol [17].
In contrast, the path of electrons in low Mr E. coli thio-
redoxin reductase was not obvious from the initial crystal
structure [22]. Both the disulfide and the pyridine nucleotide
were on the re side of the flavin, with the disulfide adjoining
the isoalloxazine ring of FAD but interposed between the
nicotinamide ring of NADPH and the flavin. There was no
histidine residue near the disulfide to catalyze dithiol±disulfide
interchange. Instead, an Asp residue proved to be the catalyst
[23]. Moreover, it did not appear possible for thioredoxin to
undergo interchange with the reductase dithiol, which was
buried near the flavin ring. A solution to these problems was
suggested by a model that emulated the domain arrangement
observed in glutathione reductase [24]. A large rotation of the
NADPH domain relative to the FAD domain would move the
redox active dithiol to the protein surface where it could react
with its protein substrate, and would position the nicotinamide
of NADPH parallel to the flavin ring. Thus, interconversion
between the observed and model conformations was proposed
to occur at two steps in the catalytic cycle. A considerable body
of mechanistic evidence supports the idea that the two con-
formations are in equilibrium in solution [25±29]. The initial
crystal structure is referred to as the FO conformation, because
the flavin and the disulfide are juxtaposed for flavin oxidation.
FR is the alternate rotated structure in which the flavin and the
pyridine nucleotide are juxtaposed to allow flavin reduction [26].
S T R U C T U R E O F E . C O L I T H I O R E D O X I N
R E D U C T A S E I N T H E F R C O N F O R M A T I O N
The properties and reactivities of complexes of thioredoxin
with thioredoxin reductase, stabilized by disulfide cross-links,
Table 1. Characterization of an enzyme family: pyridine nucleotide-disulfide oxidoreductases.
Thioredoxin reductase (2 distinct types)
Lipoamide dehydrogenase and
glutathione reductase
High Mr type Subunit Mr approximately 55 kDa
Subunit Mr approximately 55 kDa (human and Plasmodium falciparum) (all sources)
Dimeric proteins with one FAD, one redox active disulfide and a third redox active group in
each subunit. The third group is a selenenylsulfide in human TrxR and a disulfide in the P. falciparum enzyme
Dimeric proteins with one FAD and
one redox active disulfide in each
subunit
Low Mr type
Subunit Mr approximately 35 kDa (E. coli and other prokaryotes, yeast, mycoplasmas,
Giardia duodenalis, Arabidopsis thaliana and Methanococcus jannaschii)
Dimeric proteins with one FAD and one redox active disulfide in each subunit
Fig. 1. Active sites in the oxidized and two-electron reduced states. The
abbreviations are as follows: LipDH, lipoamide dehydrogenase; GR,
glutathione reductase; MR, mercuric reductase from Pseudomonas
aeruginosa Tn501; HTrxR, human thioredoxin reductase; and Pf TrxR,
Plasmodium falciparum thioredoxin reductase. Residues having numbers
without primes come from one subunit while those with primes come from
the other; the break at the bottom also symbolizes the two polypeptide
chains. The curved arrow indicates charge transfer from the donor thiolate
to the acceptor FAD. The scheme below the line represents the mixed
disulfide complex between Cys540 and TNB, where fS is the TNB anion.
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have demonstrated that these complexes are locked into the FR
conformation and do not undergo rotation to form the FO
conformer [25]. The crystal structure of a stable disulfide
complex has recently been determined (Fig. 2) [30]. In the
observed FR structure the NADPH domain has rotated about
668 as postulated by model building [24]. Reorientation of
the domains moves Cys138 away from the flavin to
accommodate the binding and reaction with thioredoxin.
The domain rearrangement simultaneously stacks the pyridine
ring of a bound pyridine nucleotide analog, 3-aminopyridine
adenine dinucleotide phosphate (AADP1), against the isoallox-
azine ring of the FAD in a position that would permit
hydride transfer during catalysis if NADPH were bound
instead.
Domain rotations thus solve the steric problems posed by the
arrangement of active site sequences in the low Mr thioredoxin
reductases from prokaryotes, lower eukaryotes, archaea, lower
plants and fungi (Table 1). Both conformations of the enzyme
are essential for completion of the catalytic cycle. The FR
conformation is required for flavin reduction by NADPH and
for reduction of the large protein substrate thioredoxin by the
enzyme dithiol. The FO conformation is required for the
transfer of electrons from the flavin to the enzyme disulfide
[26].
T H I O R E D O X I N R E D U C T A S E F R O M
H I G H E R E U K A R Y O T E S
Turning now to the high Mr thioredoxin reductase from human
placenta and from P. falciparum, we will see that a completely
different mechanism has evolved to transfer reducing equiva-
lents from the apolar interior to the disulfide substrate.
Mammalian thioredoxin reductase was isolated first from rat
liver in the seventies by Holmgren and associates, and found to
have a Mr of 55 000, like that of glutathione reductase, and
much higher than that of E. coli thioredoxin reductase [3].
Reduction of the rat liver enzyme with NADPH produced a
spectrum having long wavelength absorbance typically seen
when glutathione reductase or lipoamide dehydrogenase are
reduced to form the thiolate±flavin charge transfer complex
[16], and quite distinct from reduction of low Mr E. coli
thioredoxin reductase in which the thiolate±FAD charge
transfer complex is not stabilized and the two-electron reduced
enzyme is an equilibrium mixture of FAD±dithiol and reduced
flavin±disulfide forms [29]. Therefore, our hypothesis was that
the mechanism of high Mr thioredoxin reductase would be like
that of glutathione reductase, and quite distinct from low Mr
thioredoxin reductase; this hypothesis has been shown to be
correct but with a complication discussed below [2].
The identification of a residue of the unusual amino acid,
selenocysteine (SeC) penultimate to the C-terminal Gly residue
in human thioredoxin reductase by Stadtman and her col-
leagues was a seminal discovery [31±33]. Comparison of the
C-terminal amino-acid sequences of two high Mr thioredoxin
reductases with mercuric reductase, another member of this
enzyme family, reveals interesting contrasts. The three
enzymes have groups near their C-termini that are potentially
redox active: Cys±SeC in human thioredoxin reductase,
Cys±XXXX±Cys in P. falciparum thioredoxin reductase
and Cys±Cys in mercuric reductase (Fig. 1). The C-terminal
sequences are SGASILQAGCUG in thioredoxin reductase from
human placenta [32,33], AAKGGCGGGKCG in thioredoxin
reductase from P. falciparum [34], and FNKDVKQLSCCAG in
mercuric reductase from Pseudomonas aeruginosa Tn 501
[35,36], where U  SeC.
The C-terminal amino acids from one monomer of mercuric
reductase are adjacent to the active site disulfide of the second
monomer and it has been shown that dithiol±disulfide
interchange can occur between the nascent active site dithiol
and the C-terminal disulfide [37,38]. Extensive homology
between high Mr thioredoxin reductase and mercuric reductase
in all domains suggests that a similar structure is present in the
three enzymes as depicted in Fig. 1. It has been widely assumed
that the C-terminal groups in thioredoxin reductase must be
functional in reaction with thioredoxin and it has been our
hypothesis that they constitute evolution's second way of
transferring reducing equivalents from the apolar active site to
the enzyme surface. Alkyl hydroperoxide reductases also utilize
a second redox active disulfide, but in this case it is at the
N-terminus rather than the C-terminus [39].
Fig. 2. Drawings of the FO (left) and FR
(right) conformations of thioredoxin reductase,
based on the crystal structures of C138S (FO)
and C135S (FR) [24,30]. NADP1 and AADP1
are bound, respectively, in the two structures. The
NADPH domain (top) rotates relative to the FAD
domain in the conversion from FO to FR, as can
be seen from the positions of the bound pyridine
nucleotides and the gray helix, Na2. The pyridine
nucleotides, active site cysteines, and FAD
prosthetic groups are shown in ball-and-stick
representation. Only one subunit of the dimer is
displayed, and the thioredoxin attached to
Cys138 has been omitted from the FR structure
to simplify the view. Thioredoxin interacts
primarily with the NADPH domain but also
contacts residues from the FAD domain. The
bound pyridine nucleotide structures may
represent either NADP+ or NADPH.
6112 C. H. Williams Jr et al. (Eur. J. Biochem. 267) q FEBS 2000
To demonstrate that the C-terminal groups are directly
functional in catalysis requires at least three steps: first to
show that they are redox active; second to show that they
communicate with the redox active nascent dithiol at the active
site; and third to show that the communication is at a rate
commensurate with catalysis. It has been shown that site-
directed mutagenesis of either C-terminal Cys residue in
P. falciparum thioredoxin reductase, or of the SeC in human
thioredoxin reductase leads to loss of activity, suggesting that
they are functional [40±42]. Chemical or enzymatic modifica-
tion affecting the C-terminal residues also lead to loss of
activity but only when the redox active residues are in the
reduced state [14,43±48]. Earlier work has demonstrated
that the Cys-SeC of the mammalian thioredoxin reductase is
redox active and communicates with the active site dithiol [2].
The redox states for the groups in the C-terminal sequence
of P. falciparum thioredoxin reductase are a disulfide in the
oxidized state and a dithiol in the two-electron reduced state.
The Cys±SeC bridge in the human enzyme is a selenenylsulfide
in its oxidized state and, in the reduced state, a thiol and a
selenolate as suggested by its much lower pKa [49] (Fig. 1).
Ultimately, comparison of thioredoxin reductase isolated
from mammals with that from a causative agent of malaria,
P. falciparum, will reveal differences that may contribute to
rational drug design. For rational drug design to be effective,
the enzyme from the two sources must be different in some
significant way. In this regard, evolution seems to be on our
side because there are very considerable chemical differences
between sulfur and selenium, and the redox active residues are
separated by four residues in one species and are adjacent
in the other. Promising compounds will be required that react
maximally with the parasite enzyme and minimally with the
human thioredoxin reductase.
T I T R A T I O N W I T H N A D P H O R D I T H I O N I T E
S H O W S T H E T H I R D R E D O X A C T I V E
G R O U P I N H I G H M R T H I O R E D O X I N
R E D U C T A S E
Figure 1 will be used to discuss the dithionite and NADPH
titration data. FAD and the active site disulfide/dithiol that are
common to all members of this enzyme family are shown on
the left, and the C-terminal disulfide/dithiol, the putative new
part of the active site, is on the right. The break in the poly-
peptide chain signifies that the groups on the left come
from one subunit (residue numbers without primes) and the
C-terminal disulfide or selenenylsulfide (residue numbers with
primes) is contributed by the other subunit, as is confirmed in
the case of mercuric reductase [37]. Titration with dithionite
gives a wealth of information that assists in the interpretation of
the NADPH data. NADPH reduces glutathione reductase only
to the two-electron reduced state, the thiolate±flavin charge
transfer complex. Dithionite, being a strong reductant, first
reduces the enzyme to the thiolate±flavin charge transfer
complex but then further reduces the enzyme FAD with a
second two-electron equivalent. The conclusion is that gluta-
thione reductase has only two redox active groups, FAD and
the active site disulfide/dithiol [9]. Our understanding of the
dithionite titration of high Mr thioredoxin reductase (see below)
depended totally on having a precedent. Mercuric reductase
shows a pattern of reduction which is `diagnostic' for the
presence of an additional redox active group: it is completely
reduced in three phases. The product after the first two-electron
equivalent is shown in Fig. 1 with all of the first equivalent
taken up by the C-terminal disulfide, demonstrating that its
redox potential is higher than that of the FAD or the active site
disulfide [38]. The resulting dithiol binds mercuric ion as it
moves into the active site for reduction; as the dithiol does not
reoxidize, its function is different from that proposed for the
groups in thioredoxin reductase which are redox active in
catalysis [50].
It should be said at the outset that there are features of the
dithionite titrations of high Mr thioredoxin reductase that we do
not understand; what follows is a preliminary interpretation.
The dithionite titration of the P. falciparum enzyme is shown in
Fig. 3. Approximately 2 eq. of dithionite were required for full
thiolate±flavin charge transfer formation, in contrast to only
one equivalent required in the titration of glutathione reductase.
Thus, a third redox active group is present; the C-terminal
disulfide is redox active. The first six spectra detected during
this phase (540 nm absorbance increase) displayed a set of four
isosbestics suggesting that only two enzyme species were
Fig. 3. Reduction of thioredoxin reductase
from P. falciparum by dithionite. The oxidized
enzyme is shown in spectrum 1, fully formed
thiolate±flavin charge transfer complex is
spectrum 6 and fully reduced enzyme is
spectrum 11. The peaks at 380, 395 and 620 nm
in the final two spectra are due to methyl
viologen radical, the electron mediator. The
inset shows the data at 540 nm (circles) and at
490 nm (squares). Spectra 1±6 were analyzed
by singular value decomposition using specfit
Analysis software (Spectrum Associates,
Chapel Hill, NC, USA).
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detectable. Nevertheless, the spectra were analyzed by singular
value decomposition. Two of the three eigenvectors observed
clearly represented oxidized enzyme and fully formed thiolate±
flavin charge transfer complex (maximally formed when 2 eq.
of dithionite had been added); it was assumed that the third
eigenvector could be ascribed to the equilibrium mixture shown
in Fig. 1. Mixed disulfides that are undoubtedly intermediates
in the dithiol±disulfide interchange reaction need also to be
considered (see below) [2]. The second part of the titration of
the parasite enzyme, reduction of the thiolate±FAD charge
transfer complex (540 nm absorbance decrease), required one
equivalent of dithionite, as expected based on the behavior of
the human enzyme (see below) [2] and of glutathione reductase
[9]. The study presented in Fig. 3 has not been published and
will be presented in a more complete form elsewhere.
There are differences between the parasite and human [2]
enzymes that will require further investigation. However, both
took at least 2 eq. of dithionite to fully form the thiolate±flavin
charge transfer complex, indicating that reducing equivalents
are shared between the active site disulfide and the C-terminal
selenenylsulfide in the case of the human enzyme and the
C-terminal disulfide in the parasite enzyme (Fig. 1). The
second part of the titration of human thioredoxin reductase,
reduction of the thiolate±FAD charge transfer complex, requires
one equivalent of dithionite just as it does with glutathione
reductase [2]. The qualitative differences observed in the
dithionite titrations of human and P. falciparum thioredoxin
reductase may reflect the chemistry of selenium vs. sulfur and
give hope for rational drug design.
S O M E P R O P E R T I E S O F T H E C - T E R M I N A L
D I S U L F I D E - D I T H I O L : T H E T H I R D
C A T A LY T I C G R O U P I N T H I O R E D O X I N
R E D U C T A S E F R O M P. F A L C I P A R U M
Thioredoxin reductase from P. falciparum has been cloned and
can be expressed in E. coli [34,51]. (Until very recently it had
not been possible to express the mammalian enzyme in E. coli
because of the SeC, and even now fully active recombinant
enzyme is not yet available [42,52±54].) As mentioned above,
mutagenesis of either Cys residue comprising the C-terminal
disulfide present in P. falciparum thioredoxin reductase led to
loss of activity [41]. The two modified forms of the parasite
enzyme, C535A having Cys540 remaining and C540A
having Cys535 remaining, have been used to confirm that the
C-terminal group is redox active and that it interacts with the
active site dithiol [15]. The thiol in each mutant enzyme
was reacted with DTNB [5,5 0-dithiobis-(2-nitrobenzoic acid)]
yielding a mixed disulfide (Fig. 1, bottom). The thionitro-
benzoate (TNB) anion when released, absorbed strongly and
showed that the reaction was stoichiometric. C535A resulted in
the more reactive construct referred to as C540-TNB (Fig. 1).
With these constructs, we can pose the question of whether
the active site dithiol, having been reduced by NADPH via the
flavin, can interchange with the C-terminal mixed disulfide, all
signaled by the release of a TNB anion. NADPH reduced the
FAD; the FADH2 in turn reduced the active site disulfide; the
resulting dithiol interchanged with the C-terminal mixed disul-
fide to release a TNB anion and form a new mixed disulfide
between the interchange thiol, Cys88 and Cys540. The dithiol±
disulfide interchange was completed by the attack of the flavin
interacting thiolate, Cys93 on the new mixed disulfide to
reform the active site disulfide and Cys540 [15]. Titration of
Cys540-TNB in the mutant enzyme C535A with NADPH
showed the release of one equivalent of TNB anion as the first
equivalent of NADPH reacted. As the TNB anion is an excel-
lent leaving group, the interchange was complete, in contrast
to the titration of wild-type enzyme where dithiol±disulfide
interchange between the active center dithiol and the C-terminal
disulfide reached equilibrium. After release of the TNB anion,
the thiolate±flavin charge transfer complex formed as the
second equivalent of NADPH reacted. Thus, reducing equiva-
lents entering the mutant enzyme through the flavin can reach
the mixed disulfide in the C-terminal sequence via the active
site disulfide.
Tris(2-carboxyethyl)phosphine (TCEP), is a relatively specific
reagent for disulfide reduction [55]. TCEP reacts with a model
intramolecular disulfide to form a thiophosphonium moiety and
a thiolate; the reaction is completed by hydrolysis of the
thiophosphonium moiety. Because this reaction is reversible,
the back reaction competes with hydrolysis of the thiophos-
phonium moiety. The model reaction is therefore carried out at
lower pH so that protonation of the thiolate inhibits the back
reaction.
TCEP was used to reduce the C-terminal disulfide of
P. falciparum thioredoxin reductase and to determine if the
resulting thiol would interchange with the active site disulfide.
TCEP reacted slowly with the exposed C-terminal disulfide of
wild-type thioredoxin reductase from P. falciparum; reducing
equivalents were transferred to the active site disulfide to form
the thiolate±flavin charge transfer complex which was detected
spectrally. Thus in the enzyme, the back reaction (elimination
of the thiophosphonium moiety) was not observed due to the
competing reaction of the thiolate with the nearby active site
disulfide. Glutathione reductase from yeast with its buried
active site disulfide did not react with TCEP nor did a mutant
of P. falciparum thioredoxin reductase lacking the C-terminal
thiols. The spectra detected during formation of the thiolate±
flavin charge transfer complex were analyzed by singular value
decomposition. Two of the three eigenvectors could obviously
be ascribed to oxidized enzyme and the fully formed thiolate±
flavin charge transfer complex, while the third eigenvector was
assumed to be the mixed disulfide intermediate [2]. The charge
transfer complex formed in the reaction with TCEP was
identical to that produced by dithionite reduction (Fig. 3,
spectrum 6).
TCEP reacted with the selenenylsulfide of the human
enzyme rapidly in contrast to the disulfide of thioredoxin
reductase from P. falciparum which reacted slowly with the
reagent. The thiolate±flavin charge transfer complex was the
product with the human enzyme, as with the enzyme from
the parasite. These data show that the C-terminal disulfide or
selenenylsulfide, when reduced by TCEP, can interchange with
the active site disulfide as shown by formation of the thiolate±
flavin charge transfer complex. Kinetics of the reduction of the
two thioredoxin reductases by TCEP show that the reactivities
of the selenenylsulfide and the disulfide are different. It is clear
from these data, and the possible difference in redox potential
between the two C-terminal redox groups (suggested by their
reactivity with the nascent active site dithiol), that the two
groups give the human and parasite enzymes distinct properties.
R E D U C T I O N O F T H I O R E D O X I N
R E D U C T A S E F R O M P. F A L C I P A R U M W I T H
N A D P H : R A P I D R E A C T I O N K I N E T I C S
The reduction of thioredoxin reductase from P. falciparum by
NADPH suggested that the rate of dithiol±disulfide interchange
with the group in the C-terminal sequence may be catalytically
competent. Figure 4 shows the kinetics of thiolate±flavin charge
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transfer complex formation when the enzyme was reduced by
excess NADPH. The reductive half reaction of an altered
enzyme form lacking the C-terminal disulfide is shown for
comparison and it can be seen that it has a much simpler
pattern. The same charge transfer absorbance was formed
with both enzymes. Whereas in the wild-type enzyme five
exponential phases were required to fit the data and the reaction
was not complete in 400 ms, in the mutant enzyme only two
exponential phases were required to fit the data and the reaction
was completed in 100 ms. Given that dithiol±disulfide inter-
change takes place in two steps, formation and breakdown of
mixed disulfide, and given that 2 eq. of NADPH are required,
five exponential phases were not surprising. It is our hypothesis
that at least some of the extra phases seen in the reaction of the
wild-type enzyme but not in the mutant can be attributed to
interchange between the active site dithiol and the C-terminal
disulfide. The experiment presented in Fig. 4 has not been
published and will be presented in a more complete form
elsewhere.
Are the rates of dithiol±disulfide interchange in the reductive
half reaction rapid enough to be catalytically competent? The
substrate for P. falciparum thioredoxin reductase has only very
recently been identified (S. MuÈller and K. Becker, indepen-
dently, unpublished results). The turnover number has been
determined with P. falciparum thioredoxin in the presence of
30 mm insulin (which was included because of the low Km for
Trx) at temperatures from 4 8C (the temperature of the rapid
reaction kinetics) to 37 8C. For example, the turnover number at
4 and 25 8C is 340 min21 and 1960 min21, respectively; the
apparent Km for Trx is approximately 3 mm and the activation
energy is 12.7 kcal/mole (53 kJ´mol21). The steady-state
kinetics have also been determined in direct assays in the
absence of insulin, yielding a Km  10.6 mm (S. Kanzok and
K. Becker, personal communication). The rates ascribed to
dithiol±disulfide interchange in the reductive half reaction are
approximately 3.5 times faster than the rate of turnover and are
thus competent.
C O N C L U S I O N S
The data presented here lead to the conclusion that two ways to
catalyze the reduction of thioredoxin have evolved; more
exactly, two means of transferring reducing equivalents from
the apolar active site to the protein surface have developed. In
lower species, rotation of one domain relative to the other
brings the nascent dithiol from its position adjacent to the flavin
to the protein surface for reaction with thioredoxin, while in
higher organisms a third redox active group acts as a shuttle
between the interior and exterior of the enzyme. This is in
contrast to glutathione reductase and lipoamide dehydrogenase
where the substrates are small enough to be bound adjacent to
the interchange thiol. The differences between human and
P. falciparum thioredoxin reductase give hope that rational drug
design will be possible.
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